BioStock: Aptahem on the importance of raising sepsis awareness

Sepsis is a life-threatening condition. Every year, 50 million people are affected by sepsis, of which 11 million die.Despite this, a targeted treatment is still missing. Today, September 16, a seminar will be held in Berlin to draw attention to the consequences of sepsis and BioStock has spoken to Ingela Hallberg, licensed physician and CMO at Aptahem, a biotech developing a new treatment specifically for sepsis but also other severe inflammatory conditions.

Read the full interview with Aptahem´s CMO Ingela Hallberg at biostock.se:

https://www.biostock.se/en/2022/09/aptahem-on-the-importance-of-raising-sepsis-awareness/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/